Elicera Therapeutics Management
Management criteria checks 2/4
Elicera Therapeutics' CEO is Jamal El-Mosleh, appointed in Jan 2020, has a tenure of 4.33 years. directly owns 7.84% of the company’s shares, worth SEK2.61M. The average tenure of the management team and the board of directors is 3.8 years and 4.3 years respectively.
Key information
Jamal El-Mosleh
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.3yrs |
| CEO ownership | 7.8% |
| Management average tenure | 3.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Jamal El-Mosleh (42 yo)
4.3yrs
Tenure
Mr. Jamal El-Mosleh, M.Sc., is Co-Founder at Elicera Therapeutics AB (publ) and has been its CEO since 2020. He was a Director of Elypta AB since 2016 until September 2020. Mr. El-Mosleh served as Chief Ex...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Co-Founder | 4.3yrs | no data | 7.84% SEK 2.6m | |
| Chief Science Officer | 4.3yrs | no data | 9.44% SEK 3.1m | |
| Co-Founder & Head of Transitional Research | no data | no data | 9.44% SEK 3.1m | |
| Chief Financial Officer | 3.3yrs | no data | 0.10% SEK 34.2k | |
| Head of Regulatory Affairs | 1.3yrs | no data | no data |
3.8yrs
Average Tenure
50.5yo
Average Age
Experienced Management: ELIC's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Science Officer | 10.3yrs | no data | 9.44% SEK 3.1m | |
| Independent Director | 4.3yrs | no data | 0.20% SEK 65.2k | |
| Independent Chairman | 4.3yrs | no data | 0.34% SEK 114.3k | |
| Independent Director | 4.3yrs | no data | 0.16% SEK 53.7k | |
| Independent Director | 4.3yrs | no data | 0.20% SEK 67.9k |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: ELIC's board of directors are considered experienced (4.3 years average tenure).